SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.585
+0.035 (2.26%)
Aug 15, 2025, 10:28 AM - Market open
SLS Market Cap
SLS has a market cap or net worth of $166.90 million as of August 15, 2025. Its market cap has increased by 131.18% in one year.
Market Cap
166.90M
Enterprise Value
138.65M
1-Year Change
131.18%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since January 2, 2018, SLS's market cap has increased from $38.66M to $166.90M, an increase of 331.66%. That is a compound annual growth rate of 21.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 163.21M | 122.97% |
| Dec 31, 2024 | 73.20M | 115.37% |
| Dec 29, 2023 | 33.99M | -30.05% |
| Dec 30, 2022 | 48.59M | -44.69% |
| Dec 31, 2021 | 87.85M | 59.80% |
| Dec 31, 2020 | 54.97M | 162.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |